A4i

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
The App4Independence (A4i) is a Joint Venture between the Centre for Addiction and Mental Health (CAMH) and MEMOTEXT. A4i is a patent pending, validated, digital therapeutic with a regulatory pathway for complex behavioural health. A4i’s premier indication is to provide support, isolation-reduction and relapse-risk identification in schizophrenia/psychosis spectrum illnesses. Through research, development and user co-design, A4i has developed a portal/EMR solution and mobile application. Demonstrating significant outcomes with patients and traction with Canadian and US providers and academic health science centers, CAMH schizophrenia services have engaged in using A4i in routine care.
Company Type:
Company Website:
Company HQ State:
Ontario
Company HQ Country:
Canada
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
A4i for Schizophrenia/Psychosis
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
none
Speaker
photo
CEO
A4i